The UK Diabetes Devices Market is expected to witness growth from $591 Mn in 2022 to $887 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-30. Diabetes is becoming more common in the UK, which is raising the demand for diabetes devices. Continuous glucose monitoring systems and flash glucose monitoring systems are two examples of non-invasive and slightly invasive diabetes devices that are in increasing demand in the UK. The market is segmented by type and by the end user. Some key players in this market include Magstim, Deltex Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The UK Diabetes Devices Market size is at around $591 Mn in 2022 and is projected to reach $887 Mn in 2030, exhibiting a CAGR of 5.20% during the forecast period. The UK spend $343.38 billion on healthcare overall in 2021, a nominal rise of 7.4% over the amount spent in 2020. Real growth in total current healthcare spending in the UK increased by 7.1% in 2021 compared to 10.0% in 2020 after accounting for the effects of inflation on the general economy. In the UK, healthcare expenditures accounted for about 11.9% of GDP in 2021, which is comparable to the percentage in 2020.
The total number of diabetics in the UK as of 2021 proved 3.9 million, or about 6% of the population. Around 90% of these have type 2 diabetes, while only 10% have type 1. In addition, there are approximately 1 million untreated types 2 diabetics in the UK. Diabetes is becoming more common in the UK as well. In the UK, approximately 200,000 new cases of diabetes were diagnosed in 2019, translating to about 550 new cases per day. Type 2 diabetes accounted for about 90% of these new cases, while type 1 diabetes accounted for about 10%. Insulin is administered by means of a catheter inserted under the skin using a small instrument called an insulin pump. People with diabetes who use insulin pumps can keep better blood glucose control because they can deliver more precise insulin dosing than people who use insulin injections. With the aid of insulin pumps, diabetes management is more flexible and less constrained as people with diabetes can modify their insulin dosing to suit their particular requirements.
Market Growth Drivers
Diabetes is becoming more common in the UK, which is raising the demand for diabetes devices. Continuous glucose monitoring systems and flash glucose monitoring systems are two examples of non-invasive and slightly invasive diabetes devices that are in increasing demand in the UK. The market for diabetes devices is growing in the UK because these devices are more convenient and cause less disruption to everyday life than conventional blood glucose monitoring techniques, like finger pricks. The UK market for diabetes devices is continuously changing as new technologies and innovations are created. The market for UK Diabetes devices is expanding as a result of major developments in CGM systems, insulin pumps, and artificial pancreas systems, for instance.
Demand for more recent diabetes devices in the UK may be constrained by some patients’ preference for more conventional diabetes treatment techniques in the UK, such as insulin injections and blood glucose metres. In the UK, diabetes equipment can be pricey, and some patients might not be able to purchase it. This may impede some patients' access to the devices they require to control their diabetes and restrict the market growth of diabetes devices in the UK.
2021: Dexcom and NHS England launched a partnership in 2021 to offer the G5 continuous glucose monitoring system to qualified type 1 diabetes patients. The partnership enhances patient diabetes control while increasing access to Dexcom's CGM technology in the UK.
In the UK, the National Health Service (NHS) offers advice for the use of diabetes devices as part of its guidelines for the management of diabetes. These recommendations may have an impact on how individuals and healthcare professionals use diabetes devices. In the European Union (EU), including the UK, the sale and use of medical devices are governed by the Medical Devices Regulation (MDR), a collection of rules. Before their goods can be sold in the EU, medical device manufacturers must comply with the MDR, which includes proving the devices' safety and efficacy. In the UK, recommendations for the use of diabetes devices are provided by the National Institute for Health and Care Excellence (NICE). NICE recommendations may have an impact on how individuals and healthcare professionals use diabetes devices.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
188.8.131.52 Product Applications and Services
184.108.40.206 Recent Developments
220.127.116.11 Partnerships Ecosystem
18.104.22.168 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents
By End User (Revenue, USD Billion):
The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The market is segmented by type and by the end user.
The UK Diabetes Devices Market is studied from 2022-2030.
Magstim, Deltex Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom are the major companies operating in the UK diabetes devices market.
This report addresses